LSO at BIO 2024

Life Sciences Strategy For Ontario

Life Sciences Ontario (LSO) applauds the Ontario government’s proposed new Life Sciences Strategy.

For years, LSO and our partners from the life sciences sector have been advocating for a coordinated life sciences strategy that can help support early-stage companies, attract new investment, and encourage early adoption of Ontario-made innovations in our hospitals and health system.

We are pleased that Ontario is taking the steps needed to turn this vision into reality, including through the establishment of a Life Sciences Council that will see government work in partnership with the life sciences community to advance the strategy and ensure long-term growth and competitiveness within the sector.

Click here to read more.

Pfizer Canada, adMare BioInnovations, Shift Health and Life Sciences Ontario have partnered to produce this report which uncovers where life sciences organizations have made progress in IDEA, how IDEA initiatives have impacted individuals working in the sector, and, importantly, immediate opportunities and recommendations to guide organizations to make progress IDEA.

Click here to read more.

Click here to read more.

When reports of a then-unknown respiratory disease first emerged in January 2020, it was difficult to imagine the catastrophic health, societal and economic toll COVID-19 would unleash across the globe.

Click here to read more.

Here are a few links:

https://www.investontario.ca/life-sciences

https://www.investontario.ca/medtech

https://www.investontario.ca/pharmaceuticals

https://sourcefromontario.com/en/page/event/135814/ontario-bio-international-convention-2022